AlphaFold predicted structure
KAT6A · Q92794

Mean pLDDT
48.7/ 100
Very low
2,004 residues
Confidence breakdown
- Very high(≥ 90)17%
- Confident(70–90)10%
- Low(50–70)3%
- Very low(< 50)70%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
lysine acetyltransferase 6A
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Clefting
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedRare syndromic craniosynostosis or isolated multisuture synostosis
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedSkeletal dysplasia
autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome
neurodegenerative disease
hereditary disease
syndromic intellectual disability
Intellectual disability
autism spectrum disorder
neurodevelopmental disorder
lung carcinoma
colorectal adenocarcinoma
nodular malignant melanoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Histone acetyltransferase KAT6A
Histone acetyltransferase that acetylates lysine residues in histone H3 and histone H4 (in vitro) (PubMed:11742995, PubMed:11965546). Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity (PubMed:11965546). May act as a transcriptional coactivator for RUNX1 and RUNX2 (PubMed:12771199). Acetylates p53/TP53 at 'Lys-120' and 'Lys-382' and controls its transcriptional activity via association with PML (PubMed:23431171). May play a role in leukemogenic gene transcription (PubMed:39794553)
KAT6A · Q92794

Mean pLDDT
48.7/ 100
Very low
2,004 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0